Press releases
- Ingersoll Rand Reports Record First Quarter 2024 Revenue, Adjusted EBITDA, and Adjusted EPS Performance
- Ultima Genomics Adds Former Thermo Fisher Exec Mark Stevenson to Board of Directors
- Ingersoll Rand Declares Regular Quarterly Cash Dividend, Announces Increased Share Repurchase Authorization
- Ingersoll Rand Schedules First Quarter 2024 Earnings Release and Conference Call
- Compounding Growth: Ingersoll Rand Adds to Durability of Business with Two Acquisitions
- Ingersoll Rand to Acquire ILC Dover to Expand Presence in Life Sciences
- Ingersoll Rand to Participate in Upcoming Investor Conference
- Ingersoll Rand Declares Regular Quarterly Cash Dividend
- Ingersoll Rand Reports Record Fourth Quarter and Full Year 2023 Results
- Ingersoll Rand Scores Big: Execution of Industry-Leading Sustainability Strategy Drives Results
More ▼
Key statistics
Short selling activityProvided by S&P Global Market Intelligence
Open | -- |
---|---|
High | -- |
Low | -- |
Bid | 1,011.00 |
Offer | -- |
Previous close | -- |
Average volume | -- |
---|---|
Shares outstanding | 403.53m |
Free float | 402.87m |
P/E (TTM) | 44.09 |
Market cap | 35.70bn USD |
EPS (TTM) | 2.01 USD |
Annual div (ADY) | 1.35 MXN |
---|---|
Annual div yield (ADY) | -- |
Div ex-date | Mar 06 2024 |
Div pay-date | Mar 28 2024 |
Next div ex-date | May 15 2024 |
Next div pay-date | Jun 06 2024 |
Data delayed at least 20 minutes, as of Dec 30 1899.
More ▼